ABSTRACT We have examined the effect of prior bronchoconstriction on the bronchial responsiveness to inhaled histamine in nine normal subjects. The airway response to increasing concentrations of histamine aerosol was assessed by measurement of specific airways conductance (sGaw) in a body plethysmograph. The threshold provocative dose of histamine needed to cause a 35% fall in starting sGaw (PD35) and the steepest slope of the response were measured from cumulative log dose response curves. Histamine challenges were performed in duplicate after premedication with 0*9% sodium chloride (control) or methacholine aerosol on separate days. The mean starting sGaw did not change significantly after inhalation of 0*9% sodium chloride but methacholine caused a mean reduction in sGaw of 42%. Mean control PD35 values did not differ significantly from mean PD35 values after methacholine. The mean steepest slope of the response after methacholine was 47% lower than the mean control value. There was a significant linear relationship between starting sGaw and the steepest slope for the control and for the methacholine premedicated challenges. The reduction in slope after methacholine was accounted for by the fall in starting sGaw. Because histamine PD, was not altered by prior bronchoconstriction, it is concluded that the bronchial hyperresponsiveness of asthmatic subjects to non-specific bronchoconstrictor stimuli is unlikely to be a direct consequence of their low starting airway calibre.
for by the fall in starting sGaw. Because histamine PD, was not altered by prior bronchoconstriction, it is concluded that the bronchial hyperresponsiveness of asthmatic subjects to non-specific bronchoconstrictor stimuli is unlikely to be a direct consequence of their low starting airway calibre.
It has been proposed that one factor causing increased responsiveness of the airways of asthmatic subjects to bronchoconstrictor stimuli is their low starting airway calibre. ' In a previous study,2 in which the airway response to histamine aerosol was characterised as the dose required to lower specific airway conductance (sGaw) by 35% (that is, PD35), we found that asthmatic subjects had a lower PD3. than normal subjects. On average, the asthmatic patients had lower airway-conductance before bronchial challenge than normal subjects. When they were given bronchodilator (atropine or salbutamol) to bring prechallenge sGaw to within the normal range, PD35 also increased to within the normal range.
We wondered whether this increase in PD35 could have been a direct effect of bronchodilatation in the manner previously proposed. ' The aim of the pres-tion in airway calibre on the bronchial response to histamine. We have investigated whether pretreatment of normal subjects with a long acting bronchoconstrictor agent, methacholine, would result in bronchial hyperresponsiveness.
Methods
Nine normal, non-asthmatic subjects (table 1) were studied. They all gave informed consent to the study, which was approved by the Charing Cross Hospital ethical committee. None of the subjects suffered from hayfever or had a respiratory infection at the time of the study or during the preceding month. Subjects were asked not to smoke and not to drink caffeine containing beverages within two hours of the start of each study.
Airway calibre was assessed by determination of airways resistance in a constant volume body plethysmograph (Fenyves and Gut, Basel, Switzerland) . For each measurement, the subject panted at a frequency of 1-2 cycles per second,3 and thoracic Effect ofprior bronchoconstriction on the airway response to histamine in normal subjects (5.1 ,umol) of methacholine and two subjects 80 ,ul (10-2 ,umol) . A further control challenge with saline as premedication was performed to assess reproducibility. In each case the premedicating aerosol was inhaled five minutes before the first dose of histamine. Measurements of sGaw were made two and four minutes before the start of histamine challenge. The subjects were unaware of the nature of the premedicating solutions. At least 48 hours elapsed between successive challenge studies.
The arithmetic mean of each set of five measurements was plotted against the logarithm to base 10 of the cumulative dose of histamine delivered to the subject. Each dose response curve had an initial horizontal portion followed by a fall. As previously described,2 we determined from each curve (a) starting sGaw, measured after inhalation of premedicating drug; (b) the cumulative dose of histamine that produced a 35% fall in sGaw (PD35); and (c) the steepest slope of the response.
It was important to determine that methacholine was producing bronchoconstriction which was sustained for the 20-25 minutes required to define the dose response relationship to histamine. We therefore studied the duration of effect of methacholine on seven normal subjects, three of whom were subjects for the main experiment. Four of these subjects inhaled 40 p.l and the remaining three subjects 80 ,ul of 2-5 % methacholine hydrochloride solution to obtain a 40-50% fall in resting sGaw. Five measurements of sGaw were made at specific times after inhalation of methacholine-namely, at 2, 4, 6, and 10 minutes and subsequently at five minute intervals until the 40th minute.
The responses of the two control histamine challenges were compared with a paired t test and those of all four challenges were compared with a two factor analysis of variance.5 We accepted a p value of < 0-05 as indicating a significant difference. All results are quoted as means with standard deviations in parentheses. Effect ofprior bronchoconstriction on the airway response to histamine in normal subjects There was a significant linear relationship between starting sGaw and slope for the 18 control and for the 18 methacholine premedicated challenges ( fig  5) . There was no significant difference in the slopes of these two regression lines (p > 0-1), but their positions were significantly different (p < 0-001).
There was no significant linear relationship between starting sGaw and PD35 (fig 6) .
Discussion
In these studies we have reduced airway conductance before histamine challenge into the range previously observed in asthmatic subjects.' This manoeuvre did not increase bronchial responsiveness to histamine; PD35 for normal subjects remained five times higher than that of asthmatics. These findings do not support the hypothesis that the hyperreactivity of the asthmatic is a consequence of his reduced starting airway calibre. The effect of bronchoconstriction on the slope of the response was predictable from our previous findings.6 We have found with both histamine and methacholine challenges a positive linear correlation between starting airway conductance and slope for Chung, Snashall our previous findings, a halving the prechallenge airway conductance resulting in an approximate halving of the slope. This is an important relationship because it implies that when dose response curves from control challenges and after bronchoconstriction are adjusted by expressing airway conductance as percentage changes of the starting value they will be roughly parallel or superimposed (fig 7) , and if this is so then a single value for the intercept PD,5 describes their position. Since the regression lines shown in figure 5 do not pass through the origin, "normalisation" will result in a small error. Our observation that prior bronchoconstriction did not alter bronchial responsiveness to histamine is interesting in the light of factors which have been suggested to increase the normalised slope and decrease the intercept of the dose response curve. The hyperbolic relationship between airways resistance and calibre (Poiseuille's law), the presence of a thicker bronchial wall,7 and the increase in activity of airway irritant receptors with bronchoconstriction8 may result in an amplification of the bronchoconstrictor response and therefore in a steeper slope. In the bronchoconstricted state airway smooth muscle may be operating on a steeper part of its length tension curve, such that less histamine may be needed to induce a response and a greater degree of airway narrowing would result.' Differences in aerosol deposition may also be expected to alter the PD,s A more central deposi- Effect ofprior bronchoconstriction on the airway response to histamine in normal subjects tion of inhaled earosol is seen in the bronchoconstricted state9 and Ruffin and colleagues'0 have shown that asthmatic subjects needed much less histamine to cause a response when aerosol was deposited in the central airways than when the histamine is deposited in central and peripheral airways.
The relationship between airway calibre and responsiveness is more complex in the asthmatics and it may be difficult to dissociate changes in airway calibre from accompanying changes in airway responsiveness if both events result from similar factors. Thus during an attack of clinical asthma both the airway narrowing and airway hyperresponsiveness may be caused by bronchial inflammation and oedema. In our previous studies of asthmatic patients, in a stable clinical condition,26 we found no relationship between prechallenge airway conductance and the PD35 for histamine or methacholine, but in a group of patients with more severe asthma we may expect to find that the most severely affected have the lowest airway calibre and the highest responsiveness." '-'3 The present study on normal subjects, however, suggests that these two factors can be separated, as does the demonstration of an increased responsiveness in normal subjects after upper respiratory tract viral infections'4 or brief exposure to pollutants '5 16 
